Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record.

Amantadine reduces levodopa‐induced dyskinesias in parkinsonian monkeys

Blanchet, Pierre J., Konitsiotis, Spyridon, Chase, Thomas N.·1998·Movement Disorders

Abstract

The antidyskinetic potential of the glutamate NMDA receptor channel blocker amantadine was evaluated in four levodopa‐primed parkinsonian monkeys using two different regimens (1.25 or 2.5 mg/kg administered subcutaneously twice daily for 3–6 days). When administered with a relatively low dose of levodopa, amantadine produced a near‐total suppression of choreiform dyskinesias and a substantial reduction in dystonic dyskinesias at the expense of a significant reduction in antiparkinsonian response. With a high dose of levodopa, amantadine had a smaller but still significant effect on dyskinesias without altering the antiparkinsonian response. These results lend support to the view that glutamate receptormediated mechanisms contribute to levodopa‐induced dyskinesias. They also suggest that amantadine could alleviate such complications in parkinsonian patients, especially with careful dose optimization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.870130507

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 185

Metadata

Authors
Blanchet, P. J., Konitsiotis, S., & Chase, T. N.
Venue
Movement Disorders
Publisher
Wiley
Published
1998-09
Volume
13
Issue
5
Pages
798-802
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W2132008514
Cited by
185
References
0
FWCI
4.30
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amantadine reduces levodopa‐induced dyskinesias in parkinsonian monkeys. https://app.cochat.ai/papers/10.1002/mds.870130507
The paper
Blanchet, P. J., Konitsiotis, S., & Chase, T. N. (1998). Amantadine reduces levodopa‐induced dyskinesias in parkinsonian monkeys. Movement Disorders. https://doi.org/10.1002/mds.870130507

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.